Managing snakebite
BMJ
.
2022 Jan 7:376:e057926.
doi: 10.1136/bmj-2020-057926.
Authors
Ravikar Ralph
1
,
Mohammad Abul Faiz
2
,
Sanjib Kumar Sharma
3
,
Isabela Ribeiro
4
,
François Chappuis
5
Affiliations
1
Department of Internal Medicine, Christian Medical College, Vellore, Tamil Nadu, 632004, India
[email protected]
.
2
Dev Care Foundation, Dhaka-1209, Bangladesh.
3
Department of Internal Medicine, B.P. Koirala Institute of Health Sciences, Dharan, 76500, Nepal.
4
Dynamic Portfolio, Drugs for Neglected Diseases initiative (DNDi), 15 Chemin Louis-Dunant, 1202, Geneva, Switzerland.
5
Division of Tropical and Humanitarian Medicine, Geneva University Hospitals, Rue Gabrielle-Perret-Gentil 6, Geneva, CH 1211, Switzerland.
PMID:
34996773
PMCID:
PMC9278408
DOI:
10.1136/bmj-2020-057926
No abstract available
Publication types
Review
MeSH terms
Antivenins / therapeutic use*
Humans
Practice Guidelines as Topic
Primary Health Care / standards*
Snake Bites / therapy*
Substances
Antivenins